Visit for the latest Coronavirus Disease (COVID-19) updates.

You are here

Evidence-Based Resource Summary

Strength of Evidence: 
4 out of 4
4 out of 4
Year Published: 

Screening for Genital Chlamydia Infection

Description of Resource: 
Chlamydia is a common sexually transmitted infection (STI). Untreated infections can lead to complications, including pelvic inflammatory disease (PID) in women and testicular inflammation in men. Screening to identify and treat people who are unknowingly infected might reduce the risk of complications and transmission to others. This systematic review assessed the evidence about the effects and safety of screening to detect and treat chlamydia infection in women and men. It identified 6 trials involving 359,078 adult women and men in Denmark, the Netherlands, Peru, the UK, and the United States. The review found moderate quality evidence that chlamydia screening can reduce the risk of PID in women. It found no evidence of an effect on testicular inflammation in men.

Evidence-Based Resource Details

help Learn more about EBR criteria
Developed By: 
Cochrane Review
Developer Type: 
Non-Federal Government
Healthy People 2020 Topic Area(s): 
Sexually Transmitted Diseases
Healthy People 2020 Objectives: 
Resource Type: 
Systematic Review
Low N, Redmond S, Uusküla A, van Bergen J, Ward H, Andersen B, Götz H. Screening for genital chlamydia infection. Cochrane Database Syst Rev [Internet]. 2016 [cited 2018 Jan 23];(9). Art. No.: CD010866. doi: 10.1002/14651858.CD010866.pub2. Available from: